Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in BioNTech’s Covid-19 vaccine and in BNTX stock. Meanwhile, BioNTech has generally been generating relatively steep losses and its shares are not cheap. Finally, while its two most prominent drug candidates show some potential, they both have significant weaknesses and consequently may very well not end up generating large amounts of revenue for the firm. More News from Barchart In li ...